2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine has been researched along with zolpidem in 1 studies
| Studies (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine) | Trials (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine) | Recent Studies (post-2010) (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine) | Studies (zolpidem) | Trials (zolpidem) | Recent Studies (post-2010) (zolpidem) |
|---|---|---|---|---|---|
| 135 | 6 | 50 | 1,825 | 368 | 683 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bomsien, S; Skopp, G | 1 |
1 other study(ies) available for 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine and zolpidem
| Article | Year |
|---|---|
An in vitro approach to potential methadone metabolic-inhibition interactions.
Topics: Algorithms; Amitriptyline; Analgesics, Opioid; Atomoxetine Hydrochloride; Chromatography, Liquid; Citalopram; Clozapine; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Isoenzymes; Kinetics; Methadone; Methylation; N-Methyl-3,4-methylenedioxyamphetamine; Oxidoreductases, N-Demethylating; Propylamines; Psychotropic Drugs; Pyridines; Pyrrolidines; Tandem Mass Spectrometry; Zolpidem | 2007 |